Monthly Publications
In Depth
Subscribe Now
In Depth
coverage of timely
Life Science
Compliance issues
Subscribe Now
Browsing Category
CMS
The Impact of COVID-19 Years on the ACO REACH Model
The impact of the COVID-19 pandemic on accountable care organizations (ACOs) has yet to be determined, but according to the…
AMA Survey Finds that Prior Authorization Harms Patient Care
A recent physician survey found that the prior authorization process exceeds the benefit of the process to patients, according to…
CMS Outlines Medicare Drug Price Negotiation Program for 2026
On March 15, 2023, CMS released initial guidance detailing the requirements and parameters on key elements of the new Medicare…
CMS Releases 2024 MA Capitation Rates and Part C and D Payment Policies
On Friday, March 31, 2023, the Centers for Medicare & Medicaid Services (CMS) released the Calendar Year 2024 Medicare…
Genotox Enters Into Settlement Agreement, As Well As CIA and DPA Over False…
Recently, Genotox Laboratories Ltd. agreed to pay at least $5.9 million to resolve False Claims Act allegations that the company…
CMMI Plans to Release New Payment Models in 2023
During the Value-Based Payment Summit, Center for Medicare and Medicaid Innovation (CMMI) Director Liz Fowler, Ph.D., outlined the…
Program Safeguards Would Have Saved Medicare Money on Drug Testing Services…
From 2016 through 2020, Medicare Part B paid roughly $3 billion for 17.1 million definitive drug testing services to 3.3 million…
The Impact of Ending the Public Health Emergency on Telemedicine
On January 30, 2023, the White House issued a statement that the Biden Administration will end the COVID-19 public health…
CMMI Announces New Pilot Programs
The Biden administration proposed three pilot programs aimed at lowering costs and improving access to drugs under Medicare and…
CMS Publishes Initial Guidance Documents For Inflation Rebate Provisions
On February 9, 2023, the Centers for Medicare & Medicaid Services (CMS) published two “initial” guidance documents (Part B and…